From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder

from U.S. Food & Drug Administration

The U.S. Food and Drug Administration recently approved Cablivi injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura, a rare and life-threatening disorder that causes blood clotting. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063